Novavax, Inc (NASDAQ:NVAX) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced the appointment of Cynthia N. Oliver, Ph.D. to the position of Senior Vice President, Process Development Operations, effective April 8, 2014.Novavax, Inc. (NASDAQ:NVAX) shares after opening at $3.74 moved to $4.06 on last trade day and at the end of the day closed at $4.05 Company price to sales ratio in past twelve months was calculated as 50.70 and price to cash ratio as 5.78. Novavax, Inc. (NASDAQ:NVAX) showed a negative weekly performance of -7.11%.
SodaStream International Ltd (NASDAQ:SODA) shares are soaring in pre-market trading after a Calcalist report said the home carbonation issue may be considering selling a major stake to a larger competitor. Sodastream International Ltd (NASDAQ:SODA) shares advanced 8.12% in last trading session and ended the day on $40.75. SODA return on equity ratio is recorded as 13.50% and its return on assets is 9.30 %. Sodastream International Ltd (NASDAQ:SODA) yearly performance is -21.72%.
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it will report its first quarter 2014 financial results on Wednesday, May 7, 2014, before the market opens. Following the announcement, at 8:30 a.m. Eastern Time, company management will host a conference call and webcast discussion of the results and provide a general corporate update. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares moved up 6.05% in last trading session and was closed at $7.09 while trading in range of $6.66 – $7.10 – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) year to date (YTD) performance is 4.03%.
Zogenix, Inc (NASDAQ:ZGNX) shares climbed after the company reported that the court has granted temporary restraining order preventing the implementation of Massachusetts ban of Zohydro ER Extended-Release Capsules. Zogenix, Inc. (NASDAQ:ZGNX) weekly performance is 0.36%. On last trading day company shares ended up $2.82. Zogenix, Inc. (NASDAQ:ZGNX) distance from 50-day simple moving average (SMA50) is -24.32%. Analysts mean target price for the company is $5.73.
Leave a Reply